Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono") announced the presentation ...

In the years since the hotly debated practice was legalized, an invisible industry has emerged, a seven-month NJ.com ...

Foralumab is the first intranasal immune modulator in clinical trials for patients with Multiple System Atrophy ...

Foralumab is the first intranasal immune modulator in clinical trials for patients with Multiple System AtrophyBOSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiz ...

The law’s residency requirement was recently challenged by two New Jersey doctors, a Philadelphia resident and a Delaware ...

SynuSight Biotech (SynuSight), a clinical-stage biotech company focused on innovative pipeline development for neurodegenerative diseases, today announced the publication of a collaborative study in ...

Presentations at key medical conferences in May support advancement of Alterity’s lead drug ATH434 into Phase III development for Multiple ... Read More The post Alterity in spotlight at medical ...

Detailed price information for Alterity Therapeutics Ltd ADR (ATHE-Q) from The Globe and Mail including charting and trades.

The buildup of a protein called 𝛂-synuclein (ASN) into toxic clumps is a hallmark of synucleinopathies, a group of neurodegenerative diseases that includes Parkinson's and multiple system atrophy ...

The Chris Eaton Foundation has awarded scholarships to four deserving Albuquerque student-athletes, continuing the late coach ...

About an hour after Adam Hamawy was declared the winner of New Jersey’s 12th District Democratic primary, Rep. Mike Lawler (R ...

Research from the University of Florida, Mayo Clinic, and Vanderbilt University, in collaboration with the Parkinson's ...